Hashem Haghdoost-Yazdi Selected Research

Parkinsonian Disorders (Parkinsonism)

1/2021	Hydrogen sulfide attenuates induction and prevents progress of the 6-hydroxydopamine-induced Parkinsonism in rat through activation of ATP-sensitive potassium channels and suppression of ER stress.
11/2019	Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of KATP channels, alpha 2 adrenoceptors and anti-inflammatory mechanisms.
5/2018	Changes in the Serum Urate Level Can Predict the Development of Parkinsonism in the 6-Hydroxydopamine Animal Model.
5/2017	The Anti-Parkinsonism Effects of KATP Channel Blockade in the 6-Hydroxydopamine-Induced Animal Model: The Role of Oxidative Stress.
4/2016	Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
9/2014	Evaluation of the association between blood homocysteine concentration and the degree of behavioral symptoms in the 6-hydroxydopamine-induced Parkinsonism in rat.
9/2012	Prolonged hyperoxia preconditioning attenuates behavioral symptoms of 6-hydroxydopamine-induced Parkinsonism.
9/2012	Intracerebral injection of low amounts of norharman induces moderate Parkinsonism-like behavioral symptoms in rat.
8/2012	High intake of folic acid or complex of B vitamins provides anti-Parkinsonism effect: no role for serum level of homocysteine.
9/2011	Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hashem Haghdoost-Yazdi Research Topics

Disease

11	Parkinsonian Disorders (Parkinsonism) 01/2021 - 12/2010
10	Parkinson Disease (Parkinson's Disease) 09/2022 - 12/2010
3	Pain (Aches) 01/2022 - 11/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 05/2017
2	Nervous System Diseases (Neurological Disorders) 09/2014 - 09/2011
2	Ataxia (Dyssynergia) 09/2011 - 09/2010
1	Memory Disorders (Memory Loss) 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2022
1	Weight Gain 01/2022
1	Breast Neoplasms (Breast Cancer) 09/2015
1	Hyperoxia 09/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2012
1	Hyperhomocysteinemia 08/2012
1	Alzheimer Disease (Alzheimer's Disease) 09/2011
1	Multiple Sclerosis 09/2011
1	Dyskinesias (Dyskinesia) 09/2011
1	Type 2 Episodic Ataxia 09/2010

Drug/Important Bio-Agent (IBA)

13	Oxidopamine (6 Hydroxydopamine)IBA 09/2022 - 12/2010
4	KATP ChannelsIBA 01/2021 - 05/2017
4	Neuroprotective AgentsIBA 07/2018 - 04/2016
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021 - 01/2018
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 05/2017
3	4-Aminopyridine (4 Aminopyridine)FDA Link 04/2016 - 09/2010
3	Apomorphine FDA Link 09/2012 - 12/2010
2	Glyburide (Glibenclamide)FDA LinkGeneric 01/2018 - 05/2017
2	Vitamin B Complex (B Vitamins)IBA 05/2017 - 08/2012
2	TeaIBA 04/2016 - 09/2011
2	Tetraethylammonium (Tetraethylammonium Bromide)IBA 04/2016 - 09/2011
2	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 04/2016 - 09/2011
2	HomocysteineIBA 09/2014 - 08/2012
2	Carbolines (Beta-Carbolines)IBA 09/2012 - 12/2010
2	norharmanIBA 09/2012 - 12/2010
1	ZincIBA 09/2022
1	SeleniumIBA 09/2022
1	BilirubinIBA 09/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	Capsaicin (Zostrix)FDA Link 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	EndocannabinoidsIBA 01/2022
1	CannabinoidsIBA 01/2022
1	AM 251 (AM251)IBA 01/2022
1	sodium bisulfide (NaHS)IBA 01/2021
1	Dexmedetomidine FDA Link 11/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2019
1	Uric Acid (Urate)IBA 05/2018
1	Potassium Channels (Potassium Channel)IBA 01/2018
1	PotassiumIBA 05/2017
1	Caspase 9IBA 09/2015
1	Caspase 3 (Caspase-3)IBA 09/2015
1	Formaldehyde (Formol)FDA Link 10/2014
1	OrexinsIBA 11/2013
1	NeuropeptidesIBA 11/2013
1	Naloxone (Narcan)FDA LinkGeneric 11/2013
1	Morphine (MS Contin)FDA LinkGeneric 11/2013
1	Analgesics (Analgesic Drugs)IBA 11/2013
1	1- (2- methylbenzoxazol- 6- yl)- 3- (1,5)naphthyridin- 4- yl ureaIBA 11/2013
1	CaspasesIBA 09/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2012
1	Levodopa (L Dopa)FDA LinkGeneric 09/2011
1	NeurotoxinsIBA 12/2010
1	Nifedipine (Adalat)FDA LinkGeneric 12/2010
1	3-acetylpyridineIBA 09/2010

Therapy/Procedure

1	Analgesia 11/2013